Skip to main content
Log in

Leitfaden für die Basisdiagnostik und leitliniengerechte Therapie

Herzinsuffizienz in der Hausarztpraxis

Heart failure in the general medical practice — A guide to diagnosis and therapy

  • FORTBILDUNG . SCHWERPUNKT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Die Herzinsuffizienz hat — je nach Schweregrad — eine schlechte Prognose. Da knapp 60% dieser Patienten ausschließlich von Hausärzten betreut werden, lastet auf ihnen eine große Verantwortung. Um dieser gerecht zu werden, bringt Sie der Beitrag auf den neuesten Stand.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P and Authors/Task Force M. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European heart journal. 2016;37:2129–200.

    Article  Google Scholar 

  2. Ertl G ACE, • Bekeredjian R., Beyersdorf • F,. Güder • G., •Gummert J., Katus • H.A., Kindermann I, • Pauschinger M, Perings • S., Raake • P. W. J., Störk S., von Scheidt • W., Welz S., Böhm M. 2016 Empfehlung Aufbau und Organisation von Herzinsuffizienz-Netzwerken (HF-NETs) und Herzinsuffizienz-Einheiten („Heart Failure Units“, HFUs) zur Optimierung der Behandlung der akuten und chronischen Herzinsuffizienz. Kardiologe (2016) 10: 222 doi:101007/s12181-016-0072-6. 2016.

  3. https://www.g-ba.de/institution/themenschwerpunkte/dmp/.

  4. https://www.versorgungsatlas.de/fileadmin/ziva_docs/47/Bericht_Herzinsuffizienz_20140911_1.pdf

  5. Gheorghiade M, Vaduganathan M, Fonarow GC and Bonow RO. Rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol. 2013;61:391–403.

    Article  Google Scholar 

  6. Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, McDonagh T, Parkhomenko A, Tavazzi L, Levesque V, Mori C, Roubert B, Filippatos G, Ruschitzka F, Anker SD and Investigators C-H. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiencydagger. European heart journal. 2015;36:657–68.

    Article  CAS  Google Scholar 

  7. http://www.leitlinien.de/nvl/herzinsuffizienz. 2017.

  8. Angermann CE, Stork S, Gelbrich G, Faller H, Jahns R, Frantz S, Loeffler M, Ertl G and Competence Network Heart F. Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study. Circulation Heart failure. 2012;5:25–35.

    Article  Google Scholar 

  9. Guder G, Stork S, Gelbrich G, Brenner S, Deubner N, Morbach C, Wallenborn J, Berliner D, Ertl G and Angermann CE. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling. European journal of heart failure. 2015;17:442–52.

    Article  Google Scholar 

  10. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J and Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. The New England journal of medicine. 1999;341:709–17.

    Article  CAS  Google Scholar 

  11. Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B and Group E-HS. Eplerenone in patients with systolic heart failure and mild symptoms. The New England journal of medicine. 2011;364:11–21.

    Article  CAS  Google Scholar 

  12. Kober L, Thune JJ, Nielsen JC, Haarbo J, Videbaek L, Korup E, Jensen G, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjaer H, Brandes A, Thogersen AM, Gustafsson F, Egstrup K, Videbaek R, Hassager C, Svendsen JH, Hofsten DE, Torp-Pedersen C, Pehrson S and Investigators D. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. The New England journal of medicine. 2016;375:1221–30.

    Article  Google Scholar 

  13. Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L and Investigators S. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010;376:875–85.

    Article  CAS  Google Scholar 

  14. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, Investigators P-H and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. The New England journal of medicine. 2014;371:993–1004.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Georg Ertl.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Güder, G., Ertl, G. Herzinsuffizienz in der Hausarztpraxis. MMW - Fortschritte der Medizin 160, 32–38 (2018). https://doi.org/10.1007/s15006-018-0242-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-018-0242-5

Keywords

Navigation